Crossmark

Unleashing the immune arsenal: development of broad spectrum multiepitope bluetongue vaccine targeting conserved T cell epitopes of structural proteins

Crossref DOI link: https://doi.org/10.1186/s12864-025-12294-2

Published Online: 2026-04-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kolla, Harish Babu

Kumar, Anuj

Dutt, Mansi

Nanjundappa, Roopa Hebbandi

Singh, Karam Pal

Mertens, Peter Paul Clement

Kelvin, David

Umeshappa, Channakeshava Sokke
Funding

Funding for this research was provided by:

Canada Research Chairs (CRC 2021-00215)
License Information

Text and Data Mining valid from 2026-04-17

Accepted Manuscript valid from 2026-04-17
More Information

Article History

Received: 19 April 2025

Accepted: 3 November 2025

First Online: 17 April 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below